Literature DB >> 32306199

Advances in the management of primary bone sarcomas of the skull base.

Idara Edem1, Franco DeMonte1, Shaan M Raza2,3.   

Abstract

Skull base primary malignancies represent a heterogeneous group of histologic diagnoses and sarcomas of the skull base are specific malignant tumors that arise from mesenchymal cells and can be classified by site of origin into bony and soft tissue sarcomas. The most common bony sarcomas include: chondrosarcoma, osteosarcoma, chordoma, Ewing's sarcoma. Given the relative rarity of each histologic diagnosis, especially in the skull base, there is limited published data to guide the management of patients with skull base sarcomas. An electronic search of the literature was performed to obtain key publications in the management of bony sarcomas of the skull base published within the last decade. This article is thus a review of the multi-disciplinary management principles of primary bony sarcomas of the skull base. Of note, there have been several recent advancements in the realm of skull base sarcoma management that have resulted in improved survival. These include advances in: imaging and diagnostic techniques, surgical techniques that incorporate oncologic surgical principles, conformal radiation paradigms and targeted systemic therapies. Early access to coordinated multi-disciplinary subspecialty care immediately at suspicion of diagnosis has further improved outcomes. There are several ongoing trials in the realms of radiation therapy and systemic therapy that will hopefully provide further insight about the optimal management of bony sarcomas of the skull base.

Entities:  

Keywords:  Cancer; Management; Sarcoma; Skull base; Surgery

Year:  2020        PMID: 32306199     DOI: 10.1007/s11060-020-03497-6

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  33 in total

1.  Endoscopic endonasal approach for resection of cranial base chordomas: outcomes and learning curve.

Authors:  Maria Koutourousiou; Paul A Gardner; Matthew J Tormenti; Stephanie L Henry; Susan T Stefko; Amin B Kassam; Juan C Fernandez-Miranda; Carl H Snyderman
Journal:  Neurosurgery       Date:  2012-09       Impact factor: 4.654

2.  Petroclival Chondrosarcoma: A Multicenter Review of 55 Cases and New Staging System.

Authors:  Matthew L Carlson; Brendan P O'Connell; Joseph T Breen; Cameron C Wick; Colin L Driscoll; David S Haynes; Reid C Thompson; Brandon Isaacson; Paul W Gidley; J Walter Kutz; Jamie J Van Gompel; George B Wanna; Shaan M Raza; Franco DeMonte; Samuel L Barnett; Michael J Link
Journal:  Otol Neurotol       Date:  2016-08       Impact factor: 2.311

3.  Whole-transcriptome analysis of chordoma of the skull base.

Authors:  Diana Bell; Shaan M Raza; Achim H Bell; Gregory N Fuller; Franco DeMonte
Journal:  Virchows Arch       Date:  2016-07-11       Impact factor: 4.064

Review 4.  Chordoma: update on disease, epidemiology, biology and medical therapies.

Authors:  Anna Maria Frezza; Laura Botta; Annalisa Trama; Angelo P Dei Tos; Silvia Stacchiotti
Journal:  Curr Opin Oncol       Date:  2019-03       Impact factor: 3.645

5.  Multimodality Treatment of Skull Base Chondrosarcomas: The Role of Histology Specific Treatment Protocols.

Authors:  Shaan M Raza; Paul W Gidley; Jeanne M Meis; David R Grosshans; Diana Bell; Franco DeMonte
Journal:  Neurosurgery       Date:  2017-09-01       Impact factor: 4.654

6.  Tumors of the skull base: outcome and survival analysis of 77 cases.

Authors:  J C Irish; P J Gullane; F Gentili; J Freeman; J B Boyd; D Brown; J Rutka
Journal:  Head Neck       Date:  1994 Jan-Feb       Impact factor: 3.147

7.  Surgical Management of Primary Skull Base Osteosarcomas: Impact of Margin Status and Patterns of Relapse.

Authors:  Shaan M Raza; Ahmed Habib; Wei-Lien Wang; Paul W Gildey; Anthony P Conley; Marc-Elie Nader; Ehab Y Hanna; Shirley Y Su; Franco DeMonte
Journal:  Neurosurgery       Date:  2020-01-01       Impact factor: 4.654

8.  Clival chordomas: clinical management, results, and complications in 71 patients.

Authors:  Chandranath Sen; Aymara I Triana; Niklas Berglind; James Godbold; Raj K Shrivastava
Journal:  J Neurosurg       Date:  2009-11-20       Impact factor: 5.115

9.  Endoscopic endonasal approach in the management of skull base chordomas--clinical experience on a large series, technique, outcome, and pitfalls.

Authors:  Salvatore Chibbaro; Jan Frederick Cornelius; Sebastien Froelich; Leonardo Tigan; Pierre Kehrli; Christian Debry; Antonio Romano; Philippe Herman; Bernard George; Damien Bresson
Journal:  Neurosurg Rev       Date:  2013-11-19       Impact factor: 3.042

Review 10.  Genetic aberrations and molecular biology of skull base chordoma and chondrosarcoma.

Authors:  Yohei Kitamura; Hikaru Sasaki; Kazunari Yoshida
Journal:  Brain Tumor Pathol       Date:  2017-04-21       Impact factor: 3.154

View more
  3 in total

1.  MRI-Based Radiomics Differentiates Skull Base Chordoma and Chondrosarcoma: A Preliminary Study.

Authors:  Erika Yamazawa; Satoshi Takahashi; Masahiro Shin; Shota Tanaka; Wataru Takahashi; Takahiro Nakamoto; Yuichi Suzuki; Hirokazu Takami; Nobuhito Saito
Journal:  Cancers (Basel)       Date:  2022-07-03       Impact factor: 6.575

Review 2.  Primary Skull Base Chondrosarcomas: A Systematic Review.

Authors:  Paolo Palmisciano; Ali S Haider; Mohammadmahdi Sabahi; Chibueze D Nwagwu; Othman Bin Alamer; Gianluca Scalia; Giuseppe E Umana; Aaron A Cohen-Gadol; Tarek Y El Ahmadieh; Kenny Yu; Omar N Pathmanaban
Journal:  Cancers (Basel)       Date:  2021-11-26       Impact factor: 6.639

3.  Clinical Outcomes Following Dose-Escalated Proton Therapy for Skull-Base Chordoma.

Authors:  Adam L Holtzman; Ronny L Rotondo; Michael S Rutenberg; Daniel J Indelicato; Alexandra De Leo; Dinesh Rao; Jeet Patel; Christopher G Morris; William M Mendenhall
Journal:  Int J Part Ther       Date:  2021-06-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.